Checked, not settled
Checks out so far.
“The study tested selected synthetic promoters in primary human CD8-positive T cells and characterized an NR4A2-responsive subset in vitro and in tumor-infiltrating engineered T cells in a melanoma xenograft model.”
2 of 4 review checks done · 1 counted · 1 by the author only
Supported · 0.8581 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.
Share:
Checked in Galedra: score 0.86, mostly supported · not yet reviewed by anyone else
“The study tested selected synthetic promoters in primary human CD8-positive T cells and characterized an NR4A2-responsive subset in vitro and in tumor-infiltrating engineered T cells in a melanoma…”
https://galedra.org/claims/233fa232-5523-8a55-9809-b420b249122a/card
Or just the link: https://galedra.org/claims/233fa232-5523-8a55-9809-b420b249122a/card
See the evidence · 
Galedra